Publication | Open Access
Long-term safety and tolerability of erenumab: Three-plus year results from a five-year open-label extension study in episodic migraine
99
Citations
19
References
2019
Year
ClinicalTrials.gov NCT01952574.
| Year | Citations | |
|---|---|---|
Page 1
Page 1